Its a dual agonist, activating both GLP-1 receptors (like semaglutide) and GIP (glucose-dependent insulinotropic polypeptide) receptors
Please share your story through Legislative Action Center at the link below
It is driven by the emerging research on GLP-1R biology and by the clinical experience of practitioners working in longevity medicine
Founded as a specialized telehealth platform for GLP-1 treatments, Trimi combines licensed clinical oversight with optimized online workflows for consultation, prescription, and fulfillment
Anti-inflammatories reduce swelling and irritation in your body's tissues
Look M, Dunn JP, Kushner RF, Cao D, Harris C, Gibble TH et al (2025) Body composition changes during weight reduction with Tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight